Renovo

About:

Renovo Ltd. provides biotechnology services.

Top Investors: Atlas Venture, HealthCap, Care Capital, JPMorgan Partners

Description:

Renovo is a biopharmaceutical product company and is a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration. We aim to be first to market with a scar reduction pharmaceutical drug in the US and Europe to capitalise on this huge, unmet market need. Our pipeline includes one drug in phase 3 clinical development, two drugs in phase 2 clinical development and numerous pre-clinical candidates.

Total Funding Amount:

$33M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2000-01-01

Contact Email:

support(AT)goldenname.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2002-12-02

IPO Status:

Private

Industries: